FDX1 and hepatocellular carcinoma: Additionally, sorafenib and erastin, known inducers of ferroptosis, were found to inhibit FDX1 degradation, enhance the aggregation of copper‐dependent lipoylated proteins, and stimulate cuproptosis in primary hepatocellular carcinoma (HCC) cells.86